Koyfin Home > Directory > Health Care > Antares Pharma > Return on Capital %

Antares Pharma Return on Capital % Chart (ATRS)

Antares Pharma annual/quarterly Return on Capital % from 2001 to 2018.
  • Antares Pharma Return on Capital % for the quarter ending December 12, 2018 was -25.15 a -0.12% increase of 0.03 year over year
  • Antares Pharma Return on Capital % for the last 12 months ending December 12, 2018 was -16.94 a -35.05% increase of 5.94 year over year
  • Antares Pharma Annual Return on Capital % for 2018 was -16.94 a -17.18% increase of 2.91 from 2017
  • Antares Pharma Annual Return on Capital % for 2017 was -19.84 a -35.32% increase of 7.01 from 2016
  • Antares Pharma Annual Return on Capital % for 2016 was -26.85 a 12.00% decrease of -3.22 from 2015
Other Margins & Efficiency Metrics:
  • Antares Pharma EBITDA Margin for the quarter ending December 12, 2018 was $-27m a -45.38% increase of 12m year over year
  • Antares Pharma Return on Equity % for the quarter ending December 12, 2018 was 77.43 a 203.55% increase of 157.61 year over year
View Chart On Koyfin

Quarterly ATRS Return on Capital % Data

12/2018-25.15
09/2018-6.86
06/2018-19.02
03/2018-25.18
12/2017-16.86
09/2017-19.66
06/2017-12.78
03/2017-27.51
12/2016-22.39
09/2016-29.62

Annual ATRS Return on Capital % Data

2018-16.94
2017-19.84
2016-26.85
2015-23.63
2014-39.22
2013-16.57
2012-12.16
2011-14.68
2010-48.67
2009-57.59